ECOG-ACRIN Cancer Research Group
@eaonc.bsky.social
Biomarker-driven medical research involving adults who have or are at risk of developing cancer
Pinned
Beating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trials
An inspiring interview with a 13-year survivor of stage 4 pancreas cancer
bit.ly
After being diagnosed with #PancreaticCancer, Steven Merlin found hope through a #clinicaltrial. Now as an ECOG-ACRIN advocate, he shares his perspective on the benefits of clinical trials. Read his inspiring story: bit.ly/beatingtheod...
#FindingsFriday: ICYMI, at #ESMO25 Dr. Janice Mehnert @nyulangone.bsky.social presented results from the STAMP trial, showing that giving pembro after surgery may help prevent #MerkelCellCarcinoma from spreading to distant organs. Promising progress for this rare #SkinCancer! More: bit.ly/49uM4sa
Press Release: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer
A new clinical trials shows that pembrolizumab, a drug that utilizes the body’s immune system to target and eliminate cancer cells, appeared to reduce the risk of distant metastases for an aggressive ...
bit.ly
November 7, 2025 at 1:47 PM
#FindingsFriday: ICYMI, at #ESMO25 Dr. Janice Mehnert @nyulangone.bsky.social presented results from the STAMP trial, showing that giving pembro after surgery may help prevent #MerkelCellCarcinoma from spreading to distant organs. Promising progress for this rare #SkinCancer! More: bit.ly/49uM4sa
The recently reported DREAM3R results show that, for pts w/ pleural #mesothelioma, the addition of durvalumab to chemo = higher tumor response—yet survival benefit is unclear. More research is needed. Read about this collab between @precogonc.bsky.social & @togaanz.bsky.social: bit.ly/47Pw02S
Durvalumab Plus Chemo Yields Inconclusive Results in Advanced Pleural Mesothelioma | OncLive
Durvalumab in combination with chemotherapy produced outcomes consistent with prior studies in patients with advanced pleural mesothelioma.
bit.ly
November 6, 2025 at 3:29 PM
The recently reported DREAM3R results show that, for pts w/ pleural #mesothelioma, the addition of durvalumab to chemo = higher tumor response—yet survival benefit is unclear. More research is needed. Read about this collab between @precogonc.bsky.social & @togaanz.bsky.social: bit.ly/47Pw02S
After being diagnosed with #PancreaticCancer, Steven Merlin found hope through a #clinicaltrial. Now as an ECOG-ACRIN advocate, he shares his perspective on the benefits of clinical trials. Read his inspiring story: bit.ly/beatingtheod...
Beating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trials
An inspiring interview with a 13-year survivor of stage 4 pancreas cancer
bit.ly
November 5, 2025 at 7:21 PM
After being diagnosed with #PancreaticCancer, Steven Merlin found hope through a #clinicaltrial. Now as an ECOG-ACRIN advocate, he shares his perspective on the benefits of clinical trials. Read his inspiring story: bit.ly/beatingtheod...
DYK only 17% of US cancer trials are federally funded—yet they’re far more likely to study rare cancers, pediatric cancers, & multimodality treatments? Public funding = innovation where it’s needed most. More: bit.ly/47kYNME #Oncology #CancerResearch @swog.org
Study Finds Federally Funded Clinical Trials Play a Vital Role in Cancer Research, Especially for Rare and Pediatric Cancers
Although industry-sponsored cancer clinical trials often focus on single-agent drug trials, federally funded cancer clinical trials are more likely to investigate drug combinations with other treatmen...
bit.ly
November 5, 2025 at 2:10 PM
DYK only 17% of US cancer trials are federally funded—yet they’re far more likely to study rare cancers, pediatric cancers, & multimodality treatments? Public funding = innovation where it’s needed most. More: bit.ly/47kYNME #Oncology #CancerResearch @swog.org
The Fall 2025 Group Meeting session recordings are now available on the Attendee Hub Website.
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
October 29, 2025 at 6:40 PM
The Fall 2025 Group Meeting session recordings are now available on the Attendee Hub Website.
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Simply log in with your first name, last name, and the email address you used during registration ➡️ cvent.me/EvkYal #EAOnc
Phase 3 #ClinicalTrial EA8231 is now enrolling! This study is exploring a new treatment approach for patients with treatment-refractory locally-advanced or metastatic #UrothelialCancer. Learn more: bit.ly/ea8231-study... #TargetedTherapy
Now Enrolling: EA8231 Study for Patients With Bladder Cancer That Has Progressed Following Treatment
This phase 3 clinical trial is testing a new treatment approach for patients with treatment-refractory locally-advanced or metastatic urothelial cancer
bit.ly
October 23, 2025 at 5:11 PM
Phase 3 #ClinicalTrial EA8231 is now enrolling! This study is exploring a new treatment approach for patients with treatment-refractory locally-advanced or metastatic #UrothelialCancer. Learn more: bit.ly/ea8231-study... #TargetedTherapy
Day 2 of the #EAOnc Fall 2025 Group Meeting is underway! Let us know which sessions you are heading to today. And don’t miss our General Session at 5:30 PM! 🩺🩻📈
October 23, 2025 at 2:20 PM
Day 2 of the #EAOnc Fall 2025 Group Meeting is underway! Let us know which sessions you are heading to today. And don’t miss our General Session at 5:30 PM! 🩺🩻📈
Thank you to the exceptional presenters and panelists who helped make the Fall 2025 Comis #TranslationalScience Symposium a success: Drs. Jon Steingrimsson, @rhubbbstat.bsky.social, Paul Catalano, Walter Witschey, @jordanberlin5.bsky.social, & Mary Lou Smith!
October 22, 2025 at 8:49 PM
Thank you to the exceptional presenters and panelists who helped make the Fall 2025 Comis #TranslationalScience Symposium a success: Drs. Jon Steingrimsson, @rhubbbstat.bsky.social, Paul Catalano, Walter Witschey, @jordanberlin5.bsky.social, & Mary Lou Smith!
The Comis #TranslationalScience Symposium continues with talks by Dr. Paul Catalano of @danafarber.bsky.social @hsph.harvard.edu & Dr. Walter Witschey @pennmedicine.bsky.social. #AI #imaging
October 22, 2025 at 8:01 PM
The Comis #TranslationalScience Symposium continues with talks by Dr. Paul Catalano of @danafarber.bsky.social @hsph.harvard.edu & Dr. Walter Witschey @pennmedicine.bsky.social. #AI #imaging
First up: talks from Dr. Jon Steingrimsson & Dr. @rhubbbstat.bsky.social, both of @brownbiostatistics.bsky.social, on #AI, #MachineLearning, & #RealWorldData in cancer #ClinicalTrials. More to come!
October 22, 2025 at 7:32 PM
First up: talks from Dr. Jon Steingrimsson & Dr. @rhubbbstat.bsky.social, both of @brownbiostatistics.bsky.social, on #AI, #MachineLearning, & #RealWorldData in cancer #ClinicalTrials. More to come!
Group Co-Chair Dr. Mitch Schnall of @pennmedicine.bsky.social kicks off the Fall 2025 Robert L. Comis Translational Science Symposium, focused on #AI, #RealWorldData, and alternative approaches to phase 2 and 3 therapeutic questions. #EAOnc
October 22, 2025 at 7:15 PM
Group Co-Chair Dr. Mitch Schnall of @pennmedicine.bsky.social kicks off the Fall 2025 Robert L. Comis Translational Science Symposium, focused on #AI, #RealWorldData, and alternative approaches to phase 2 and 3 therapeutic questions. #EAOnc
The Robert L. Comis, MD Translational Science Symposium on Approaches Using #AI and Other Electronic Methods in #ClinicalTrials is underway. Join us in Salon E, 5th Floor! #EAOnc #CancerResearch
October 22, 2025 at 7:09 PM
The Robert L. Comis, MD Translational Science Symposium on Approaches Using #AI and Other Electronic Methods in #ClinicalTrials is underway. Join us in Salon E, 5th Floor! #EAOnc #CancerResearch
Congratulations to the Fall 2025 Edith Peterson Mitchell, MD Travel Scholars! #CancerResearch #ClinicalTrials #EAOnc
October 22, 2025 at 6:03 PM
Congratulations to the Fall 2025 Edith Peterson Mitchell, MD Travel Scholars! #CancerResearch #ClinicalTrials #EAOnc
Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium! 🩻🩺📈#EAOnc
October 22, 2025 at 3:54 PM
Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium! 🩻🩺📈#EAOnc
#Immunotherapy after surgery shows potential in preventing spread of aggressive skin cancer. STAMP (EA6174) results at #ESMO25 by Dr. Janice Mehnert of NYU Langone’s Perlmutter Cancer Center. Largest study to date to evaluate pembrolizumab as adjuvant therapy for #MerkelCellCarcinoma bit.ly/4hgQrJg
Press Release: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer
A new clinical trials shows that pembrolizumab, a drug that utilizes the body’s immune system to target and eliminate cancer cells, appeared to reduce the risk of distant metastases for an aggressive ...
bit.ly
October 22, 2025 at 3:22 PM
#Immunotherapy after surgery shows potential in preventing spread of aggressive skin cancer. STAMP (EA6174) results at #ESMO25 by Dr. Janice Mehnert of NYU Langone’s Perlmutter Cancer Center. Largest study to date to evaluate pembrolizumab as adjuvant therapy for #MerkelCellCarcinoma bit.ly/4hgQrJg
The #EAOnc Fall 2025 Group Meeting officially begins today! Looking forward to seeing you in Philadelphia. Check in at the registration desk on the 5th floor before heading to your first session. 🩺🩻📈
October 22, 2025 at 1:00 PM
The #EAOnc Fall 2025 Group Meeting officially begins today! Looking forward to seeing you in Philadelphia. Check in at the registration desk on the 5th floor before heading to your first session. 🩺🩻📈
You may be eligible to participate in a #PancreaticCancer study, EA2192/APOLLO, for patients with #PancreaticCancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation. Learn more: bit.ly/apollo-trial #pancsm
October 1, 2025 at 4:17 PM
You may be eligible to participate in a #PancreaticCancer study, EA2192/APOLLO, for patients with #PancreaticCancer that has been surgically removed and has a BRCA1, BRCA2, or PALB2 mutation. Learn more: bit.ly/apollo-trial #pancsm
Reposted by ECOG-ACRIN Cancer Research Group
Congratulations to Anthony Letai, MD, PhD, on being named the new director of the National Cancer Institute. His appointment is a testament to our continuing commitment to innovation and collaboration.
Learn more: bit.ly/4pRWiZy
Learn more: bit.ly/4pRWiZy
September 29, 2025 at 9:05 PM
Congratulations to Anthony Letai, MD, PhD, on being named the new director of the National Cancer Institute. His appointment is a testament to our continuing commitment to innovation and collaboration.
Learn more: bit.ly/4pRWiZy
Learn more: bit.ly/4pRWiZy
We congratulate Dr. Anthony Letai on his appointment as NCI Director. His deep scientific expertise & reputation as a collaborative leader make him an excellent choice to drive progress against #cancer. We look forward to working with him! #CancerResearch #ClinicalTrials
September 30, 2025 at 4:45 PM
We congratulate Dr. Anthony Letai on his appointment as NCI Director. His deep scientific expertise & reputation as a collaborative leader make him an excellent choice to drive progress against #cancer. We look forward to working with him! #CancerResearch #ClinicalTrials
Today is #WorldCancerResearchDay! Catch up on the latest
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
September 24, 2025 at 4:26 PM
Today is #WorldCancerResearchDay! Catch up on the latest
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
@eaonc.bsky.social research highlights from our August newsletter here ➡️https://bit.ly/aug25research #EAOnc #CancerResearch
Today is the 2025 Rally for Medical Research! #RallyForNIH unites patients, survivors, researchers & advocates urging Congress to make National Institutes of Health funding a national priority.
Join us in calling for sustained, robust NIH support. Important info➡️ rallyformedicalresearch.org
Join us in calling for sustained, robust NIH support. Important info➡️ rallyformedicalresearch.org
September 18, 2025 at 4:19 PM
Today is the 2025 Rally for Medical Research! #RallyForNIH unites patients, survivors, researchers & advocates urging Congress to make National Institutes of Health funding a national priority.
Join us in calling for sustained, robust NIH support. Important info➡️ rallyformedicalresearch.org
Join us in calling for sustained, robust NIH support. Important info➡️ rallyformedicalresearch.org
#NIH research is the basis for countless treatments and cures for patients battling life-threatening and chronic conditions. Join today’s #RallyMedRes & urge Congress to support robust, sustained funding for NIH. Tools & resources here: rallyformedicalresearch.org #FundNIH
Home - Rally for Medical Research
Join advocates from around the country for the 2025 Rally for Medical Research! The Hill Day will take place on Thursday, September 18, with advocates ... Read moreHome
RallyForMedicalResearch.org
September 18, 2025 at 1:22 PM
#NIH research is the basis for countless treatments and cures for patients battling life-threatening and chronic conditions. Join today’s #RallyMedRes & urge Congress to support robust, sustained funding for NIH. Tools & resources here: rallyformedicalresearch.org #FundNIH
ICYMI: Check out our round-up of recently published
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
September 10, 2025 at 4:23 PM
ICYMI: Check out our round-up of recently published
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
@eaonc.bsky.social research results. More here ➡️ bit.ly/aug25research #EAOnc
September is #ProstateCancerAwarenessMonth 💙. This month, we’re spotlighting EA8191/INDICATE, a #ClinicalTrial treating #ProstateCancer that has come back after surgery with apalutamide and targeted radiation based on PET imaging. More here: bit.ly/indicate-trial
September 10, 2025 at 2:39 PM
September is #ProstateCancerAwarenessMonth 💙. This month, we’re spotlighting EA8191/INDICATE, a #ClinicalTrial treating #ProstateCancer that has come back after surgery with apalutamide and targeted radiation based on PET imaging. More here: bit.ly/indicate-trial
More good news from Washington: Last week the House Labor-HHS Subcommittee advanced its FY26 spending bill, increasing both NCI & NIH funding and rejecting the proposed cuts. Thank you for working to prioritize #CancerResearch, patients, and survivors. Read more: bit.ly/4n3sYNN
House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99M House joins Senate in rejecting Trump’s proposed 40% NIH cuts - The Cancer Letter
The House is on track to join the Senate in rejecting the Trump administration’s budget proposal that would cut NIH by $18 billion. To access this subscriber-only content please log in or subscribe.If...
bit.ly
September 8, 2025 at 6:30 PM
More good news from Washington: Last week the House Labor-HHS Subcommittee advanced its FY26 spending bill, increasing both NCI & NIH funding and rejecting the proposed cuts. Thank you for working to prioritize #CancerResearch, patients, and survivors. Read more: bit.ly/4n3sYNN